2022 MMIT Patient Choice Awards Finalist

Senderra is a 2022 MMIT Patient Choice Awards Finalist!

7th Annual MMIT Patient Choice Awards

Senderra is a finalist in the Managed Markets Insight & Technology (MMIT) seventh-annual Specialty Pharmacy Patient Choice Awards as ranked by patient satisfaction survey results from the previous year.

Each year, MMIT recognizes specialty pharmacies that provide best-in-class customer satisfaction and overall patient care.

2022 Award Finalist

Senderra is honored to be a finalist this year in the Independent Specialty Pharmacy category. This honor confirms Senderra’s ongoing commitment to keeping people first and providing exceptional patient care.

About senderra

Senderra is a national specialty pharmacy, serving patients with challenging and ongoing medical conditions through provision of specialty medications, clinical expertise and support services. 

We dedicate ourselves to designing and executing a model to serve the needs of our patients and partners (Prescribers, Pharma and Payers) in order to make a difference and effect positive outcomes.